Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study of umbilical cord mesenchymal stem cells to treat autoimmune hepatitis, sponsored by Beijing 302 Hospital; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Autoimmune Hepatitis | Phase 1, Phase 2 | Status: UNKNOWN